Cor Vasa 2013, 55(4):e341-e344 | DOI: 10.1016/j.crvasa.2013.03.014

Inflammatory cardiomyopathy: Still many questions await answers

Tomáš Palečeka,b
a II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha, Česká republika
b International Clinical Research Center, Brno, Česká republika

Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Paleček T. Inflammatory cardiomyopathy: Still many questions await answers. Cor Vasa. 2013;55(4):e341-344. doi: 10.1016/j.crvasa.2013.03.014.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. P. Elliott, B. Andersson, E. Arbustini, et al., Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, European Heart Journal 29 (2008) 270-276. Go to original source...
    2. A. Aleksova, G. Sabbadini, M. Merlo, et al., Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure-a subgroup analysis from the Trieste Cardiomyopathy Registry, Journal of Cardiovascular Medicine 10 (2009) 699-705. Go to original source... Go to PubMed...
    3. J. Stehlik, L.B. Edwards, A.Y. Kucheryavaya, et al., The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report - 2010, Journal of Heart and Lung Transplantation 29 (2010) 1089-1103. Go to original source... Go to PubMed...
    4. N.K. Lakdawala, B.H. Funke, S. Baxter, et al., Genetic testing for dilated cardiomyopathy in clinical practice, Journal of Cardiac Failure 18 (2012) 296-303. Go to original source... Go to PubMed...
    5. A.M. Feldman, D. McNamara, Myocarditis, The New England Journal of Medicine 343 (2000) 1388-1398. Go to original source... Go to PubMed...
    6. I. Kindermann, C. Barth, F. Mahfoud, et al. Update on myocarditis, Journal of the American College of Cardiology 59 (2012) 779-792. Go to original source... Go to PubMed...
    7. P. Richardson, W. McKenna, M. Bristow, et al., Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies, Circulation 93 (1996) 841-842. Go to original source...
    8. H.T. Aretz, M. Billingham, E. Olsen, et al., Myocarditis: the Dallas criteria, Human Pathology 18 (1987) 619-624. Go to original source...
    9. K.L. Baughman, Diagnosis of myocarditis: death of Dallas criteria, Circulation 113 (2006) 593-595. Go to original source... Go to PubMed...
    10. J.W. Mason, J.B. O'Connell, A. Herskowitz, et al., A clinical trial of immunosuppressivetherapy for myocarditis, The New England Journal of Medicine 333 (1995) 269-275. Go to original source... Go to PubMed...
    11. H.P. Schultheiss, Dilated cardiomyopathy-a chronic myocarditis? New aspects on diagnosis and therapy, Zeitschrift für Kardiologie 82 (Suppl. 4) (1993) S25-S32.
    12. U. Kühl, M. Pauschinger, H.P. Schultheiss, Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation, Internist 38 (1997) 590-601. Go to original source... Go to PubMed...
    13. B. Maisch, B. Bultman, S. Factor, et al., World Heart Federation consensus conference's definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy, Heartbeat 4 (1999) 3-4.
    14. B. Maisch, S. Pankuweit, Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy, Herz 37 (2012) 644-656. Go to original source... Go to PubMed...
    15. H.P. Schultheiss, U. Kühl, L.T. Cooper, The management of myocarditis, European Heart Journal 32 (2011) 2616-2625. Go to original source... Go to PubMed...
    16. P. Kuchynka, T. Paleček, S. Šimek, et al., Inflammatory cardiomyopathy: current concepts regarding its diagnosis and treatment, Cor et Vasa 51 (2009) 32-37. Go to original source...
    17. A. Frustaci, M.A. Russo, C. Chimenti, Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study, European Heart Journal 30 (2009) 1995-2002. Go to original source... Go to PubMed...
    18. T. Paleček, P. Kuchynka, D. Hulínska, et al., Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy, Medical Microbiology and Immunology 199 (2010) 139-143. Go to original source... Go to PubMed...
    19. U. Kühl, M. Pauschinger, P.L. Schwimmbeck, et al., Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction, Circulation 107 (2003) 2793-2798. Go to original source... Go to PubMed...
    20. A.L. Caforio, F. Calabrese, A. Angelini, et al., A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis, European Heart Journal 28 (2007) 1326-1333. Go to original source... Go to PubMed...
    21. U. Kühl, M. Pauschinger, B. Seeberg, et al., Viral persistence in the myocardium is associated with progressive cardiac dysfunction, Circulation 112 (2005) 1965-1970. Go to original source... Go to PubMed...
    22. H.J. Why, B.T. Meany, P.J. Richardson, et al., Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy, Circulation 89 (1994) 2582-2589. Go to original source...
    23. I. Kindermann, M. Kindermann, R. Kandolf, et al., Predictors of outcome in patients with suspected myocarditis, Circulation 118 (2008) 639-648. Go to original source... Go to PubMed...
    24. J. Krejčí, H. Poloczková, P. Hude, et al., Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters, Cor et Vasa 55 (2013) e333-e340. Go to original source...
    25. F. Kuethe, J. Lindner, K. Matschke, et al., Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis, Clinical Infectious Diseases 49 (2009) 1660-1666. Go to original source... Go to PubMed...
    26. U. Lotze, R. Egerer, B. Glück, et al., Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury, Journal of Medical Virology 82 (2010) 1449-1457. Go to original source... Go to PubMed...
    27. F. Kuethe, H.H. Sigusch, K. Hilbig, et al., Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy, American Heart Journal 153 (2007) 850-858. Go to original source... Go to PubMed...
    28. C.T. Bock, K. Klingel, R. Kandolf, Human parvovirus B19-associated myocarditis, The New England Journal of Medicine 362 (2010) 1248-1249. Go to original source... Go to PubMed...
    29. O. Zimmermann, M. Kochs, T.P. Zwaka, et al., Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy, International Journal of Cardiology 104 (2005) 92-100. Go to original source... Go to PubMed...
    30. W.A. Teeter, J.T. Thibodeau, K. Rao, et al., The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation, American Heart Journal 164 (2012) 358-364. Go to original source... Go to PubMed...
    31. R. Sheppard, P.J. Mather, J.D. Alexis, et al., Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2, Journal of Cardiac Failure 18 (2012) 675-681. Go to original source... Go to PubMed...
    32. J.J. McMurray, S. Adamopoulos, S.D. Anker, et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, European Heart Journal 33 (2012) 1787-1847.

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes